Patients

Age

Sex

Symptoms

ENMG

Treatments

Evolution

Short and medium term

Long term (2 ans)

1

2

M

TPG (HS: 5) + P + M + BNI

AMAN

C + CBZ + PARA

RP (7j); DH (102j)

D

2

2

F

TPG (HS: 4)

AMAN

C

DH (18j)

D

3

5

M

TPS (HS: 2) + P

AMAN

C + CBZ

RP (5j); DH (32j)

HS: 2

4

4

F

TPG (HS: 4) + P + PFP

AMAN

C + CBZ

RP (8j); DH (18j)

HS: 3

5

6

M

TPG (HS: 4) + P + ANO

AMAN

C + CBZ

RP (8j); DH (22j)

D

6

5

M

TPG (HS: 4) + BPFP

AMSAN

C+

DH (18j)

HS: 4

7

5

M

TPG (HS: 4) + P

AMSAN

C + CBZ

RP (3j); DH (32j)

HS: 3

8

16

M

TPG (HS: 4) + P + M

ADIP

C + CBZ + PARA

RP (5j); DH (15j)

HS: 0

9

10

M

TPG (HS: 4) + BPFP

ADIP

C+

DH (33j)

HS: 0

10

14

F

TPG (HS: 4) + P

ADIP

C + CBZ

RP (5j); DH (16j)

HS: 0

11

4

M

TPG (HS: 5) + BNI

ADIP

C

DH (42j)

HS: 0

12

8

M

TPS (HS: 3)

ADIP

C+

DH (10j)

HS: 1

13

12

M

TPG (HS: 4) + P + M

ADIP

C + CBZ + PARA

RP (5j); DH (16j)

HS: 0

14

7

F

TPG (HS: 4) + PFP

ADIP

C+

DH (8j)

HS: 0

15

12

M

TPG (HS: 4) + P

ADIP

C + CBZ

RP (3j); DH (15j)

HS: 0

16

9

M

TPG (HS: 4)

ADIP

C+

DH (3j)

HS: 1